Live Breaking News & Updates on Orexigen Therapeutics

Stay updated with breaking news from Orexigen therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Nearly 10 years since the approval of naltrexone/bupropion, there’s been no CV outcomes study, leaving safety in question. ....

Orexigen Therapeutics , Drug Administration , Committee For Medicinal Products Human Use , Takeda Pharmaceuticals , European Medicines Agency , Contrave Currax Pharmaceuticals , Medicinal Products , Human Use , Currax Pharmaceuticals ,

Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates

/PRNewswire/ Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines. ....

United States , San Diego , Oleg Butovsky , Jay Hagan , Prestons Klassen , Lou Gehrig , Preston Klassen , Howardl Weiner , Curtisa Monnig , Exchange Commission , Foundation For Neurologic Diseases Boston , Orexigen Therapeutics , Program Updates , Rnas The Company Or Regulus , Development Leadership , Regulus Therapeutics Inc , Development Rd Expenses , Arena Pharmaceuticals , Head Of Research Development , Autosomal Dominant Polycystic Kidney Disease , Multiple Ascending Dose , Vice President , Regulus Therapeutics , Amyotrophic Lateral Sclerosis , Neurologic Diseases , January Therapeutics ,

Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates

Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Howardl Weiner , Oleg Butovsky , Lou Gehrig , Preston Klassen , Prestons Klassen , Curtisa Monnig , Jay Hagan , Head Of Research Development , Development Leadership , Development Rd Expenses , Program Updates , Foundation For Neurologic Diseases Boston , Exchange Commission , Rnas The Company Or Regulus , Orexigen Therapeutics , Regulus Therapeutics Inc , Arena Pharmaceuticals , Autosomal Dominant Polycystic Kidney Disease , Multiple Ascending Dose , Vice President , Regulus Therapeutics , Amyotrophic Lateral Sclerosis , Neurologic Diseases , January Therapeutics ,

E.U. investigates Ozempic, Saxenda after suicidal thoughts reported

E.U. investigates Ozempic, Saxenda after suicidal thoughts reported
nbcnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcnews.com Daily Mail and Mail on Sunday newspapers.

United States , City Of , United Kingdom , Sanofi Acomplia , Eli Lilly , Markus Manns , Orexigen Therapeutics , Union Investment , Icelandic Medicines Agency , European Medicines Agency , Novo Nordisk , Kings College , Vivus Inc ,

Health: EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported

Health: EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United States , City Of , United Kingdom , Markus Manns , Eli Lilly , Sanofi Acomplia , Novo Nordisk , Orexigen Therapeutics , Drug Administration Adverse Event Reporting System , Vivus Inc , Kings College , Union Investment , Icelandic Medicines Agency , Co Mounjaro , European Medicines Agency , Public Dashboard ,